相似文献
1
CD45: all is not yet crystal clear.
Immunology. 2006 Feb;117(2):145-55. doi: 10.1111/j.1365-2567.2005.02265.x.
2
CD45 in memory and disease.
Arch Immunol Ther Exp (Warsz). 2002;50(2):85-93.
3
Impaired CD45-associated tyrosine phosphatase activity during HIV-1 infection: implications for CD3 and CD4 receptor signalling.
Biochem Biophys Res Commun. 1998 Nov 9;252(1):69-77. doi: 10.1006/bbrc.1998.9595.
4
Altered CD45 expression and disease.
Trends Immunol. 2006 Mar;27(3):146-53. doi: 10.1016/j.it.2006.01.001. Epub 2006 Jan 18.
5
The role of CD45 in T-cell activation--resolving the paradoxes?
Immunol Today. 1992 Dec;13(12):477-81. doi: 10.1016/0167-5699(92)90021-X.
6
CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling.
Nature. 2001 Jan 18;409(6818):349-54. doi: 10.1038/35053086.
7
The leukocyte common antigen (CD45) of the Pacific hagfish, Eptatretus stoutii: implications for the primordial function of CD45.
Immunogenetics. 2002 Jul;54(4):286-91. doi: 10.1007/s00251-002-0469-1. Epub 2002 Jun 19.
8
Protein tyrosine phosphatases in T cell physiology.
Mol Immunol. 2004 Jul;41(6-7):687-700. doi: 10.1016/j.molimm.2004.04.015.
9
Regulation of the p70zap tyrosine protein kinase in T cells by the CD45 phosphotyrosine phosphatase.
Eur J Immunol. 1995 Apr;25(4):942-6. doi: 10.1002/eji.1830250413.
10
Regulation of basal tyrosine phosphorylation of the B cell antigen receptor complex by the protein tyrosine phosphatase, CD45.
J Immunol. 1992 Nov 15;149(10):3182-90.
引用本文的文献
1
Exploring the Relationship Between Immune Cells and Chronic Kidney Disease by Mendelian Randomization, Colocalization Analysis, and SMR.
Mediators Inflamm. 2025 Apr 16;2025:4279158. doi: 10.1155/mi/4279158. eCollection 2025.
2
Local delivery of cell surface-targeted immunocytokines programs systemic antitumor immunity.
Nat Immunol. 2024 Oct;25(10):1820-1829. doi: 10.1038/s41590-024-01925-7. Epub 2024 Aug 7.
3
Distinct early role of PTEN regulation during HCMV infection of monocytes.
Proc Natl Acad Sci U S A. 2024 Mar 19;121(12):e2312290121. doi: 10.1073/pnas.2312290121. Epub 2024 Mar 14.
4
Local delivery of cell surface-targeted immunocytokines programs systemic anti-tumor immunity.
bioRxiv. 2024 Jan 3:2024.01.03.573641. doi: 10.1101/2024.01.03.573641.
5
CD45-Directed CAR-T Cells with CD45 Knockout Efficiently Kill Myeloid Leukemia and Lymphoma Cells In Vitro Even after Extended Culture.
Cancers (Basel). 2024 Jan 12;16(2):334. doi: 10.3390/cancers16020334.
6
Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapy.
Sci Transl Med. 2023 Sep 20;15(714):eadi1145. doi: 10.1126/scitranslmed.adi1145.
7
Effects of Immune Cell Heterogeneity and Protein Corona on the Cellular Association and Cytotoxicity of Gold Nanoparticles: A Single-Cell-Based, High-Dimensional Mass Cytometry Study.
ACS Nanosci Au. 2023 Apr 24;3(4):323-334. doi: 10.1021/acsnanoscienceau.3c00001. eCollection 2023 Aug 16.
8
The identification of key genes and pathways in glioblastoma by bioinformatics analysis.
Mol Cell Oncol. 2023 Aug 14;10(1):2246657. doi: 10.1080/23723556.2023.2246657. eCollection 2023.
9
Expression of Fibrosis-Related Genes in Liver and Kidney Fibrosis in Comparison to Inflammatory Bowel Diseases.
Cells. 2022 Jan 18;11(3):314. doi: 10.3390/cells11030314.
10
Protein tyrosine phosphatase receptor type C (PTPRC or CD45).
J Clin Pathol. 2021 Sep;74(9):548-552. doi: 10.1136/jclinpath-2020-206927. Epub 2021 May 26.
本文引用的文献
1
A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells.
J Exp Med. 2005 May 2;201(9):1421-33. doi: 10.1084/jem.20042294.
2
The strength of receptor signaling is centrally controlled through a cooperative loop between Ca2+ and an oxidant signal.
Cell. 2005 Apr 22;121(2):281-93. doi: 10.1016/j.cell.2005.02.036.
3
Structural basis for the function and regulation of the receptor protein tyrosine phosphatase CD45.
J Exp Med. 2005 Feb 7;201(3):441-52. doi: 10.1084/jem.20041890. Epub 2005 Jan 31.
4
Lyn tyrosine kinase: accentuating the positive and the negative.
Immunity. 2005 Jan;22(1):9-18. doi: 10.1016/j.immuni.2004.12.004.
5
CD45 signals outside of lipid rafts to promote ERK activation, synaptic raft clustering, and IL-2 production.
J Immunol. 2005 Feb 1;174(3):1479-90. doi: 10.4049/jimmunol.174.3.1479.
6
A novel CD45 transcript involving the alternative splicing of a new exon is widely distributed in lymphoid tissues.
Hum Immunol. 2004 Dec;65(12):1539-45. doi: 10.1016/j.humimm.2004.08.181.
7
CD45 (PTPRC) as a candidate gene in multiple sclerosis.
Mult Scler. 2004 Dec;10(6):614-7. doi: 10.1191/1352458504ms1115oa.
8
A transmembrane protein-tyrosine phosphatase receptor type C (CD45) exon A point mutation (77 C to G) is not associated with the development of type 1 diabetes mellitus in a German population.
Eur J Immunogenet. 2004 Dec;31(6):245-7. doi: 10.1111/j.1365-2370.2004.00479.x.
9
Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites.
Glycobiology. 2005 Feb;15(2):153-64. doi: 10.1093/glycob/cwh151. Epub 2004 Sep 22.
10
Disease associations and altered immune function in CD45 138G variant carriers.
Hum Mol Genet. 2004 Oct 15;13(20):2377-84. doi: 10.1093/hmg/ddh276. Epub 2004 Aug 27.
Zotero 插件